Chronic Myeloid Leukemia Clinical Trials in Portland, Oregon

4 studies are recruiting for chronic myeloid leukemia in Portland, Oregon right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of Olverembatinib (HQP1351) in Patients With CML-CP

    Study comparing efficacy and safety of olverembatinib (investigational arm) vs. bosutinib (control arm) in patients with CML-CP (Part A). Study will also evaluate efficacy and safety of olverembatinib (single-arm) in CML-CP patients with T315I mutation (Part B). Patients who meet ELN 2025 failure c…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Ascentage Investigative Site #1139, Portland, Oregon
    Locations
    163 in total
    Run by
    Ascentage Pharma Group Inc.

    See if you can join NCT06423911 on ClinicalTrials.gov

  2. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the earl…

    Stage
    Not phased
    Ages
    40 to 75
    Site
    Providence Portland Medical Center, Portland, Oregon
    Locations
    745 in total
    Run by
    Alliance for Clinical Trials in Oncology

    See if you can join NCT05334069 on ClinicalTrials.gov

  3. A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

    The purpose of this study is to evaluate the safety, tolerability and determine the recommended dose for further clinical evaluation of ELVN-001 in patients with chronic myeloid leukemia with and without T315I mutations in patients who are relapsed, refractory or intolerant to TKIs.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Oregon Health & Science University-Knight Cardiovascular Institute, Portland, Oregon
    Locations
    45 in total
    Run by
    Enliven Therapeutics

    See if you can join NCT05304377 on ClinicalTrials.gov

  4. A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

    The goal of the study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of TERN-701, a highly selective allosteric inhibitor of BCR-ABL1, in participants with previously treated chronic phase - chronic myeloid leukemia (CP-CML). The study has two parts: Part 1…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Oregon Health & Science University, Portland, Oregon
    Locations
    54 in total
    Run by
    Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

    See if you can join NCT06163430 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.